Flow Cytometry in Drug Discovery and Development
暫譯: 藥物探索與開發中的流式細胞術
Litwin, Virginia M., Chattopadhyay, Pratip K.
相關主題
商品描述
Apply flow cytometry to drug discovery and development
The growth of immunotherapy and cellular therapies has dramatically expanded flow cytometry's role in drug development, while, in parallel, advances in single-cell analysis have transformed the field. Now in its Second Edition, Flow Cytometry in Drug Discovery and Development focuses on pharmaceutical applications, helping translational scientists apply flow cytometry and helping cytometrists understand the pharmaceutical applications.
Where other references concentrate on general laboratory protocols or instrument specifications, this book targets the intersection of single-cell analysis and drug development. It equips readers to evaluate drug and therapy quality using high-content analytical techniques including multiparametric analysis of single cells.
Readers will also find:
- Guidance on applying simultaneous multiparametric single-cell analysis to pharmaceutical quality assessment and therapeutic development programs
- Updated content reflecting the dramatic expansion of immunotherapy and cellular therapy applications since the first edition
- Practical frameworks connecting flow cytometry techniques to specific stages within the drug discovery and development pipeline
- Coverage of related technologies advancing single-cell analysis beyond conventional flow cytometry for drug development contexts
- Perspectives relevant to professionals across academia, contract research organizations, biotech, and pharmaceutical industry settings
Designed for pharmaceutical and biotech scientists, analytical chemists, clinical investigators, bioengineers, and university researchers, this Second Edition serves professionals working at the intersection of single-cell analysis and drug development. Instrument vendors supporting drug development workflows will also find it a targeted resource.
商品描述(中文翻譯)
將流式細胞術應用於藥物探索與開發
免疫療法與細胞療法的蓬勃發展,大幅拓展了流式細胞術在藥物開發中的角色;與此同時,單細胞分析技術的進步也徹底改變了這個領域。第二版《Flow Cytometry in Drug Discovery and Development》聚焦於製藥應用,協助轉譯科學家應用流式細胞術,也幫助細胞分析專家了解其在製藥領域中的應用。
其他參考書通常著重於一般實驗室操作流程或儀器規格,本書則鎖定單細胞分析與藥物開發的交會領域。本書提供讀者所需的知識,讓其能運用高內容分析(high-content analysis)技術評估藥物與療法的品質,其中包括對單細胞進行多參數分析(multiparametric analysis)。
讀者還能從本書獲得:
• 將同步多參數單細胞分析應用於製藥品質評估與治療開發計畫的指引
• 反映自第一版以來免疫療法與細胞療法應用大幅擴展的更新內容
• 將流式細胞術技術連結至藥物探索與開發流程中特定階段的實務架構
• 涵蓋在藥物開發情境中,推動單細胞分析超越傳統流式細胞術的相關技術
• 適用於學術界、委託研究機構(CRO)、生技業與製藥業專業人士的觀點
本第二版專為製藥與生技科學家、分析化學家、臨床研究人員、生物工程師及大學研究人員所設計,服務於單細胞分析與藥物開發交會領域工作的專業人士。支援藥物開發工作流程的儀器供應商,也能從本書中獲得一份具高度針對性的參考資源。
作者簡介
VIRGINIA M. LITWIN, PhD, is a thought-leader in validation and standardization for flow cytometry. She is President of the International Society for the Advancement of Cytometry and in 2023 received the International Clinical Cytometry Society Coulter award in recognition of her contributions to the science, education and practice of Clinical Cytometry. She chaired Clinical and Laboratory Standards Institute Committees for H62 and H42.
PRATIP K. CHATTOPADHYAY, PhD, is internationally recognized for his work developing and applying single-cell technologies, having played central roles in the introduction of various dyes, instrument platforms, and informatic approaches commonly used today. His career spans government (NIH), academics (Founding Director, NYU Precision Immunology Laboratory), and entrepreneurship (CEO, Founder, Talon Biomarkers).
作者簡介(中文翻譯)
VIRGINIA M. LITWIN, PhD,是流式細胞術驗證與標準化領域的思想領袖。她現任 International Society for the Advancement of Cytometry 主席,並於 2023 年獲得 International Clinical Cytometry Society Coulter 獎,以表彰她對 Clinical Cytometry 科學、教育與實務的貢獻。她曾擔任 Clinical and Laboratory Standards Institute H62 與 H42 委員會主席。
PRATIP K. CHATTOPADHYAY, PhD,因致力於開發與應用單細胞技術而享譽國際,並在多種現今普遍使用的染劑、儀器平台與資訊分析方法的導入過程中扮演核心角色。他的職涯涵蓋政府機構(NIH)、學術界(NYU Precision Immunology Laboratory 創辦主任),以及創業領域(Talon Biomarkers 執行長兼創辦人)。